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Background: Bifidobacteria belong to one of the predominant bacterial groups in the intestinal microbiota of
infants and adults. Several beneficial effects on the health status of their human hosts have been demonstrated
making bifidobacteria interesting candidates for probiotic applications. Adhesion of probiotics to the intestinal
epithelium is discussed as a prerequisite for colonisation of and persistence in the gastrointestinal tract.
Results: In the present study, 15 different strains of bifidobacteria were tested for adhesion. B. bifidum was
identified as the species showing highest adhesion to all tested intestinal epithelial cell (IEC) lines. Adhesion of B.
bifidum S17 to IECs was strongly reduced after treatment of bacteria with pronase. These results strongly indicate
that a proteinaceous cell surface component mediates adhesion of B. bifidum S17 to IECs. In silico analysis of the
currently accessible Bifidobacterium genomes identified bopA encoding a lipoprotein as a B. bifidum-specific gene
previously shown to function as an adhesin of B. bifidum MIMBb75. The in silico results were confirmed by Southern
Blot analysis. Furthermore, Northern Blot analysis demonstrated that bopA is expressed in all B. bifidum strains tested
under conditions used to cultivate bacteria for adhesion assays. The BopA gene was successfully expressed in E. coli
and purified by Ni-NTA affinity chromatography as a C-terminal His6-fusion. Purified BopA had an inhibitory effect
on adhesion of B. bifidum S17 to IECs. Moreover, bopA was successfully expressed in B. bifidum S17 and B. longum/
infantis E18. Strains overexpressing bopA showed enhanced adhesion to IECs, clearly demonstrating a role of BopA
in adhesion of B. bifidum strains.
Conclusions: BopA was identified as a B. bifidum-specific protein involved in adhesion to IECs. Bifidobacterium
strains expressing bopA show enhanced adhesion. Our results represent the first report on recombinant
bifidobacteria with improved adhesive properties.
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Bifidobacteria are Gram-positive bacteria that represent
one of the major genera of the intestinal tract of humans
and animals [1]. Several beneficial effects on the health
status of the human host have been claimed to be
related to the presence of bifidobacteria in the colon
(reviewed in [2-4]), thus they become increasingly inter-
esting for probiotic applications in pharmaceutical and* Correspondence: christian.riedel@uni-ulm.de
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reproduction in any medium, provided the ordairy products. Several criteria are used for the selection
of probiotic strains. Besides manufacturing criteria and
shelf life, species- and strain-specific properties related
to the probiotic effects are of major importance [5,6].
One of the most commonly tested parameters is the
ability of a probiotic to colonise the gastrointestinal tract
(GIT) of the host. This is associated with resistance to
the conditions of the GIT (low pH, high concentration of
bile salts) and adhesion to mucus and/or IECs. While
there are a number of studies assessing the adhesion of
probiotic bacteria quantitatively [7-10] to date only very
few have investigated adhesion of these organisms from a
mechanistic point of view. Most mechanistic studies onl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and



























































































Figure 1 Adhesion of different Bifidobacterium strains to IECs.
Adhesion of B. bifidum strains S16, S17, NCC189 and NCIMB41171, B.
breve strains S27 and DSM20213, B. longum/infantis strains E18 and
NCC200, B. adolescentis strains NCC251 and DSM20083, B. lactis
strains NCC362 and L15, B. animalis MB254, and B. longum strains
NCC2705 and DSM20219 to T84 (black bars), Caco-2 (light grey bars)
and HT29 (dark grey bars) cells. Adherent bacteria were determined
as colony forming units on MRSC agar plates and expressed as
percentage of the initially added bacteria (108 cfu/well). Values are
mean± standard deviation of one representative of at least three
independent experiments performed in triplicate measurements.
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such as enteropathogenic E. coli (EPEC), Salmonella sp.,
streptococci, and Listeria monocytogenes [11-14].
Nevertheless, a few authors have reported on the
mechanisms of adhesion of probiotic bacteria. Since a
number of tools for the genetic modification of lactoba-
cilli are available these organisms have been the subjects
of most of these studies [15]. By contrast, very little is
known on the mechanisms of bifidobacterial adhesion to
IECs. Adhesion of B. breve strain 4 to IECs is mediated
by a proteinaceous component present on the cell sur-
face and in spent culture supernatant [16]. Binding of
human plasminogen in vitro was shown for four bifido-
bacterial strains belonging to three different species (B.
lactis, B. bifidum and B. longum) and this process is
believed to play a role in the interaction with host tissues
[17-19]. A cell surface lipoprotein was shown to be
involved in adhesion of B. bifidum MIMBb75 to IECs
[20]. Moreover, adhesion of this strain to Caco-2 and
HT29 cells was dependent on environmental conditions,
such as pH and the presence of sugars and bile salts [21].
However, while adhesion might play an important role
in establishing administered probiotic bacteria in the in-
testinal tract of the host, to date no direct correlation be-
tween the health-promoting properties of probiotics and
their adhesion to IECs and/or mucus could be shown.
Recently, our group could describe for the first time a
correlation between adhesion of bifidobacteria to IECs
and their anti-inflammatory capacity in vitro. Bifidobac-
teria showed strain- and species-specific adhesion to
Caco-2 and T84 cells [22,23]. Furthermore, the inhibition
of LPS-induced NF-κB activation, pro-inflammatory gene
expression and IL-8 secretion in IECs by bifidobacteria
in vitro is strain- and dose-dependent [22,24]. Interest-
ingly, those strains that showed high levels of adhesion
were also those that performed best in inhibiting LPS-
induced NF-κB activation [22]. Two strains with oppos-
ing characteristics were thus further tested in different
murine models of intestinal inflammation. In all models,
animals treated with B. bifidum S17, a highly adherent
strain, were protected from weight loss, had a normalised
colonic weight to length ratio and showed improved
histological scores. By contrast, the weakly adherent B.
longum/infantis E18 had no protective effect [22,25].
Based on these results, the strain B. bifidum S17 was
selected to investigate its adhesive properties aiming to
identify the components involved in adhesion to T84,
Caco-2 and HT29 cells and to improve the adhesive
properties of this and other bifidobacterial strains.
Results
Adhesion of different Bifidobacterium strains to IECs
In previous studies, different bifidobacteria were shown
to adhere in a strain-specific manner to T84, Caco-2 andHT29 cells [22,23]. The results indicated that especially
strains of B. bifidum showed high adhesion to IECs.
However, only a limited number of strains were tested.
Thus, adhesion to different cell lines of IECs was tested
with an extended range of strains including four B. bifi-
dum strains. In line with previous observations, bifido-
bacteria adhered to all tested IEC lines in a strain-
specific manner. In comparison to all other Bifidobacter-
ium strains tested, B. bifidum strains showed significantly
higher levels of adhesion to IECs, with adhesion rates of
up to 30% depending on the cell line used (Figure 1;
Additional file 1: Table SA1). Of note, all of the tested
strains showed lower adhesion to HT29 compared to
T84 and Caco-2 cells.
We and others have recently sequenced and published
the genomes of different strains of B. bifidum [26,27].
Based on in silico analysis, several proteins with domains
known or supposed to be involved in interaction with
host tissue were identified in the genome sequence of B.
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include a protein with high homology to the bifidobac-
terial outer protein A (BopA), which has been described
as a lipoprotein associated with the cell wall of B. bifi-
dum MIMBb75 and was shown to be involved in adhe-
sion to cultured IECs [20]. Since B. bifidum strains
showed higher adhesion to IECs than all other strains
tested, we hypothesised that BopA is a unique feature of
the B. bifidum strains involved in the strong adhesion of
this species to IECs.
Homologies between BopA-coding loci of different B.
bifidum strains
In order to identify possible homologues of BopA in bifi-
dobacteria, the sequence of bopA was compared to all bifi-
dobacterial genome sequences publically available on the
NCBI web site using BLASTanalysis. The analysis covered
32 genomes including the following species: B. bifidum
(strains S17, PRL2010, and NCIMB41171), B. longum ssp.
longum (strains NCC2705, DJO10A, BBMN68, F8,
JCM1217, JDM301, and KACC 91563), B. longum ssp.
infantis (strains 157 F and ATCC 15697), B. breve (strains
UCC2003, DSM20213, and ACS-071-V-Sch8b), B. adoles-
centis (strains ATCC15703 and L2-32), B. dentium (strains
Bd1, ATCC 27678, ATCC 27679, and JCVIHMP022),
B. animalis ssp. lactis (strains AD011, BB-12, BLC1, Bl-04,
DSM10140, and V9), B. pseudocatenulatum DSM20438,
B. catenulatum DSM16992, B. angulatum DSM20098 and






100 % 99% 99
100 % 100 % 99
99
Figure 2 Homologies between BopA regions of B. bifidum strains. Com
NCIMB41171, PRL2010 and MIMBb75 encoding bopA and adjacent genes b
sized proportional to the length of the genes (length in basepairs is indica
compared to the B. bifidum S17 protein are indicated in percent. For B. bifid
upstream of oppD and downstream of pepC.indeed present only in B. bifidum strains since in no other
genome a protein with significant homology to BopA was
found (Additional file 2: Table SA2).
The locus encoding bopA was further analysed by
comparing the respective loci of those B. bifidum strains
for which sequence data was publically available. These
strains included B. bifidum S17, NCIMB41171, PRL2010
and MIMBb75 (NCBI accession numbers: CP002220,
NZ_ABQP00000000, CP001840, AM710395; Figure 2).
This analysis revealed that bopA is part of a putative
peptide-specific ATP-binding cassette (ABC) transport
system with similarity to oligopeptide permease (Opp) of
other bacteria. In Salmonella typhimurium the trans-
porter is encoded by the oppABCDF operon, in which
OppA represents the solute binding protein, OppB and
OppC are two permeases that span the cytoplasmic
membrane, and OppD and OppF are the ATP-binding
and ATP-hydrolysing proteins [28,29]. B. subtilis pos-
sesses a functional equivalent of the Opp peptide trans-
porter, encoded by the operon oppABCDF, which is
similar in sequence and organisation to that of Gram-
negative bacteria [30,31]. However, the Bacillus OppA is
linked to the cytoplasma membrane via a lipid anchor
and it has been shown OppF is not essential for func-
tionality of the transporter [31,32].
The analysis of bifidobacterial genomes revealed that
various species sequenced so far harbour genes with simi-
larity to the opp genes of B. subtilis and S. typhimurium
(data not shown). In B. bifidum strains the oppA4000 6000 8000
pD bopA pepC xth
 % 98 % % 99% 99
 %
 % 99 %
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99 %
parative in silico analysis of the genomic loci of B. bifidum S17,
y BLAST analysis. Open reading frames (ORFs) are indicated as arrows
ted in the scale). Identities of the deduced amino acid sequences
um MIMBb75 no sequence information is available for the regions
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oppF, a pepC gene coding for an aminopeptidase C has
been identified in the opp locus of B. bifidum strains
downstream of bopA on the opposite strand (Figure 2;
Additional file 3: Table SA3). The BopA protein of B. bifi-
dum MIMBb75 is annotated as putative solute binding
protein and was shown to harbour a potential thioacyla-
tion site for covalent linkage to a conserved cysteine resi-
due in the lipobox motif [20].
Comparative in silico analysis of the bopA region of
various B. bifidum strains showed that the bopA gene is
highly conserved in this species (Figure 2 and additional
File 4: Figure S1). The deduced amino acid sequence of
BopA from B. bifidum S17 shows 98% identity with
BopA of B. bifidum NCIMB41171 and 99% identity with
BopA of B. bifidum PRL2010 and B. bifidum MIMBb75,
respectively (Figure 2). Furthermore, all sequences
harbour the conserved cysteine residue in the lipobox
motif (Additional file 4: Figure S1).
Detection and expression analysis of bopA in B. bifidum
strains
To confirm the results of the in silico analysis, Southern
Blot analysis was performed on genomic DNA of all Bifi-
dobacterium strains tested for adhesion (Figure 3A). For
this purpose, genomic DNA of all strains was digested
with EcoRI since in silico analysis indicated that the bopA
genes of the sequenced strains do not harbour an EcoRI
restriction site. When digested DNA was probed for the
presence of bopA homologues using a digoxygenin-
labelled 1,812 bp probe covering the entire bopA gene

































Figure 3 Detection of bopA in B. bifidum strains and expression analy
chromosomal DNA of B. bifidum strains S16, S17, NCC189 and NCIMB41171
NCC200, B. adolescentis strains NCC251 and DSM20083, B. lactis strains NCC
DSM20219. As positive control for hybridisation, a non-labelled PCR produc
was performed by Northern Blot using RNA isolated from B. bifidum strains
medium. As negative control RNA isolated from B. longum/infantis E18 was
of oligonucleotides used for amplification of the probe for Southern Blot (1B. bifidum strains (S16, S17, NCC189 and NCIMB41171;
Figure 3A). By contrast, the probe did not hybridise to
genomic DNA of any of the other strains tested indicat-
ing that these strains do not harbour a gene with hom-
ology to bopA.
In order to verify whether bopA is expressed, Northern
Blot analysis was performed for the four B. bifidum
strains (S16, S17, NCC189 and NCIMB41171) using
RNA isolated from bacteria grown under conditions
used for adhesion assays. Using a bopA-specific
digoxygenin-labelled probe (Figure 3C) a signal could be
detected for all four B. bifidum strains tested (Figure 3B).
However, signal intensities were variable amongst the
strains. Nevertheless, these results demonstrate that
bopA is expressed in these strains after growth in MRSC
medium for 16 h under standard conditions. Since bifi-
dobacteria were cultivated under these conditions to
perform adhesion assays it is assumed that BopA is
present on the surface of these strains when used for ad-
hesion assays. In summary, the results of these experi-
ments suggest that BopA is a B. bifidum-specific
lipoprotein with a role in the strong adhesion of B. bifi-
dum strains to IECs.
Adhesion of B. bifidum S17 is mediated by a cell surface
protein
We hypothesized that BopA is involved in the strong ad-
hesion of B. bifidum strains to IECs. To gain further
insight into the chemical nature of the structures
involved in adhesion, B. bifidum S17 was treated with
1 mM sodium periodate, 1 mg/ml lipase (type II from









































sis. (A) Southern Blot analysis for bopA homologues using
, B. breve strains S27 and DSM20213, B. longum/infantis strains E18 and
362 and L15, B. animalis MB254, and B. longum strains NCC2705 and
t of bopA of B. bifidum S17 was used. (B) Expression analysis of bopA
S16, S17, NCC189 and NCIMB41171 after growth for 16 h in MRSC
used. (C) Schematic representation of the bopA locus with localisation
,812 bp) and Northern Blot (489 bp).
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bifidum S17. Preliminary experiments revealed that the
protein pattern of the cell wall fraction is already signifi-
cantly altered after 30 min of pronase or lipase treat-
ment (Figure 4A) and bacteria remained viable during
treatments for at least 60 min (Figure 4B). Thus, bacteria
treated for 30 min were used in subsequent adhesion
experiments.
Adhesion experiments with treated B. bifidum S17 to
the three IEC lines T84, Caco-2 and HT29 showed
significantly decreased adhesion after treatment with
1 mg/ml pronase (Figure 4C). In comparison to un-
treated B. bifidum S17, adhesion of pronase-treated
bacteria to all cell lines tested was reduced to about
40%. Treatment of B. bifidum S17 with 1 mM period-
ate or 1 mg/ml lipase had no significant effect on ad-
hesion for any of the tested IECs. Collectively these
results suggest that a protein on the surface of intact
bacteria of B. bifidum S17 is involved in adhesion to
IECs.
Adhesion of B. bifidum S17 in competition to purified
BopA-His6
To further demonstrate that BopA is involved in adhe-
sion of B. bifidum S17 to IECs, a C-terminal His6-fusion
of BopA (BopA-His6) was expressed in E. coli BL21
(DE3) pMGS_PBAD_bopAHis6 (Table 1). Expression of
BopA-His6 was induced in exponentially growing bac-




































Figure 4 Adhesion of treated B. bifidum S17 in comparison to untreat
30 min treatment with 1 mM periodate, 1 mg/ml lipase or 1 mg/ml pronas
B. bifidum S17 (black circles) or during treatment with 1 mM pronase (whit
triangles). Samples were taken after 0 (pre-treatment control), 15, 30, 45, an
on MRSC agar plates. (C) Adhesion of B. bifidum S17 treated for 30 min wit
(black bars), Caco-2 (light grey bars) and HT29 (dark grey bars) cells. 108 cfu
determined after growth on MRSC agar plates and expressed as percentag
of one representative of at least three independent experiments performed
pairwise comparison to the respective positive control (i.e. adhesion of unt
statistical significance (a: p< 0.05; b: p< 0.01; c: p< 0.001).induction, bacteria were harvested and crude extracts
were prepared.
SDS-PAGE revealed a predominant band in crude
extracts of bacteria induced with L-arabinose, which was
absent in non-induced bacteria (Figure 5A). This band
had a molecular mass of approximately 66 kDa, which is
consistent with the predicted molecular mass of BopA-
His6. Additionally, Western Blot using anti-His6 anti-
bodies confirmed that the predominant band in the gel is
a His-tagged protein of the expected size of BopA-His6
(Figure 5B).
For protein purification the cytoplasmic fraction of E.
coli BL21 (DE3) pMGS_PBAD_bopAHis6 containing the
majority of BopA-His6 as shown by SDS-PAGE (data
not shown) was applied to the Ni-NTA column. Bound
protein was eluted from the column by increasing con-
centrations of imidazole and collected in different frac-
tions. A single peak of protein was detected by
absorbance at 280 nm at a concentration of 40 mM
imidazole (data not shown). All fractions collected dur-
ing the peak of absorbance were pooled and dialysed. A
single band of protein with a size of approximately
66 kDa corresponding to BopA-His6 protein was
detected by SDS-PAGE and Western Blot in the pooled
fractions (lanes 3 in Figure 5A and B).
For competitive adhesion assays, IECs were pre-
incubated with 1, 10 or 100 μg/ml of purified BopA-His6
for 1 h prior to addition of intact bacteria of B. bifidum




















ed bacteria. (A) SDS-PAGE of cell wall fractions of B. bifidum S17 after
e. 50 μg of protein were loaded in each lane. (B) Viability of untreated
e circles), 1 mg/ml lipase (black triangles) or 1 mg/ml periodate (white
d 60 minutes and colony forming units were determined after growth
h either 1 mM periodate, 1 mg/ml lipase or 1 mg/ml pronase to T84
/well of treated bacteria were added to IECs. Adherent bacteria were
e relative to untreated bacteria. Values are mean± standard deviation
in triplicate measurements. Statistical analysis was performed by
reated B. bifidum S17) using Students t-test. Letters above bars indicate
Table 1 Bacterial strains and plasmids used in this study
Strain Relevant characteristics Reference
E. coli
DH10B Cloning host Invitrogen™
BL21 (DE3) Expression host Invitrogen™
Bifidobacterium
B. bifidum S17 intestinal isolate from
a breast-fed infant
[23]
B. bifidum S16 intestinal isolate from
a breast-fed infant
[23]
B. bifidum NCC189 NCC
B. bifidum NCIMB41171 NCIMB
B. breve S27 intestinal isolate from
a breast-fed infant
This study
B. breve DSM20213 type strain, intestinal
isolate from an infant
DSMZ
B. longum/infantis E18 intestinal isolate from
an adult
[23]
B. longum/infantis NCC200 NCC
B. longum NCC2705 type strain NCC
B. longum DSM20219 type strain, intestinal
isolate from an adult
DSMZ
B. adolescentis NCC251 type strain NCC
B. adolescentis DSM20083 type strain, intestinal
isolate from an adult
DSMZ
B. lactis NCC362 type strain NCC




B. animalis MB254 type strain [23]
Plasmids
pMDY23 E. coli-Bifidobacterium shuttle
vector harbouring the gusA
reporter gene, Spcr
[33]
pMGS_PBAD_bopAHis6 pMGS containing bopA
under control of arabinose-
inducible PBAD promoter
This study
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tested. Moreover, 10 μg/ml protein was sufficient to sig-
nificantly reduce adhesion to T84 and HT29 cells (Fig-
ure 5C). Of note, as little as 1 μg/ml of purified BopA-
His6 produced a similar reduction in adhesion of intact
bacteria. However, these effects did not reach statistical
significance. To exclude unspecific inhibition of adhe-
sion, control experiments were performed in which cells
were pre-incubated with 100 μg/ml BSA instead of puri-
fied BopA. This did not affect adhesion of B. bifidum
S17 to IECs (Figure 5C).
In summary, adhesion of B. bifidum S17 to all IEC
lines tested was significantly reduced after incubation ofIECs with purified BopA-His6, clearly demonstrating
that B. bifidum S17 competes with purified BopA-His6
for binding sites on IECs.
Adhesion of bifidobacteria overexpressing bopA
In order to test if expression of bopA in bifidobacteria
results in strains with improved adhesion characteristics,
the recombinant strains B. bifidum S17 pMGS_Pgap_bo-
pAHis6 and B. longum/infantis E18 pMGS_Pgap_bopA-
His6 were generated. When these strains were cultured
o/N in MRSC medium under standard conditions no
additional protein bands were detected in total bacterial
lysates by SDS-PAGE (data not shown). However, weak
but consistent signals were detected by His6-specific
Western Blot (Figure 6A and B) demonstrating success-
ful expression of BopA-His6 in these strains.
Both strains were then compared to their wildtype par-
ental strains in adhesion experiments. Adhesion of B.
bifidum S17 pMGS_Pgap_bopAHis6 to T84 cells was sig-
nificantly increased to about 150% in comparison to B.
bifidum S17 wildtype (Figure 6C). A similar increase in
adhesion was observed when Caco-2 cells were used,
however this effect was not significant. No improvement
was observed for adhesion of B. bifidum S17
pMGS_Pgap_bopAHis6 to HT29 cells. B. longum/infantis
E18 is a strain that showed only very weak adhesion to
the tested cell lines in previous experiments. Expression
of bopA in this strain resulted in a highly increased adhe-
sion to all IECs tested (T84: 511%; Caco-2: 180%; HT29:
209%) compared to B. longum/infantis E18 wildtype
(Figure 6D).
In summary, the results of adhesion experiments with
B. bifidum S17 and B. longum/infantis E18 strains
expressing BopA-His6 further confirm the previous
results and demonstrate that BopA plays an important
role in adhesion to T84 and Caco-2 cells.
Discussion
Adhesion of probiotic bacteria to IECs and mucus is
thought to help these organisms to persist in the intes-
tinal tract for prolonged periods of time, thus increasing
the chances to exert their health-promoting effects. Fur-
thermore, adhesion of probiotics to host cells could be
an important prerequisite for the immunmodulatory
effects of probiotics and was proposed to have a role in
the competitive exclusion of pathogenic bacteria by
competing for attachment sites [34-37]. As a conse-
quence, adhesion to IECs is one of the criteria for the se-
lection of probiotic strains for nutraceutical applications.
However, in healthy individuals, the luminal surface
of the small and large intestinal epithelium is covered
with a thick layer of secreted mucus consisting of two
distinct layers: an inner layer firmly attached to the





















Figure 5 Adhesion of B. bifidum S17 in competition to purified BopA-His6. SDS-PAGE (A) and Western Blot (B) for detection of BopA-His6
in crude extract of E. coli BL21 (DE3) pMGS_bopAHis6 before (lane 1) or after (lane 2) induction with 0.013 mM L-arabinose. Lane 3: purified
BopA-His6 protein in pooled and dialysed fractions of the Ni-NTA-affinity chromatography. M: protein ladder. (C) Adhesion of B. bifidum S17 to
T84 (black bars), Caco-2 (light grey bars) and HT29 (dark grey bars) cells after pre-incubation with 1, 10 or 100 μg/ml BopA-His6. As control IECs
were incubated with 100 μg/ml BSA instead of BopA-His6. Adherent bacteria were determined after growth on MRSC agar plates. Results are
shown as percent adherent bacteria relative to the positive control (untreated cells). Values are mean± standard deviation of one representative
of at least three independent experiments performed in triplicate measurements. Statistical analysis was performed by pairwise comparison to the
respective positive control (i.e. adhesion of B. bifidum S17 without pre-incubation with protein) using Students t-test. Letters above bars indicate
statistical significance (a: p< 0.05; b: p< 0.01; c: p< 0.001).
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to colonize the outer layer, the inner firmly attached
layer is devoid of bacteria [39,40] thus questioning the
importance of adhesion to IECs for activity and colon-
isation of probiotics under normal circumstances. How-
ever, under conditions of intestinal inflammation the
mucus barrier is reduced and can be penetrated by bac-
teria [41-43]. Thus, under these conditions adhesion of
probiotic bacteria to IECs might contribute to persist-
ence of these organisms in the intestinal tract of the
host for prolonged periods of time, thus increasing the
chances to exert their health-promoting effects.
Here, we investigate the adhesive properties of B. bifi-
dum S17, a strain with potent anti-inflammatory capacity
both in vitro and in vivo [22,24], aiming to identify the
components involved in adhesion to IECs and to improve
the adhesive properties of this and other promising pro-
biotic candidate strains. All analysed B. bifidum strains
showed markedly better adhesion than other strains to
all cell lines tested and all strains contained a bopA
homolog, which is highly conserved among these strains.
The three genes located upstream of bopA showed sig-
nificant similarity to genes encoding the membrane per-
mease subunits (oppBC) and an ATP-binding and -
hydrolysing protein (oppD) of ABC transport systems.
Downstream of bopA, a gene with high similarity to bac-
terial aminopeptidase C (pepC) was identified, which is
transcribed in the opposite direction. An oppA
homologue has been found in the opp operons of other
Bifidobacterium genomes. However, the amino acid se-
quence of OppA of these strains shares no significant
similarity with BopA.There is a considerable amount of studies demonstrat-
ing lipoproteins as solute binding proteins of ABC trans-
porters that mediate uptake of nutrients [44]. Moreover,
lipoproteins of ABC transport systems are often asso-
ciated with bacterial adhesion. For example, the lipopro-
tein P100 of Mycoplasma hominis is an OppA-like
substrate-binding protein of a peptide transport system
that has been characterised as multifunctional protein.
In addition to cytoadherence P100 has been shown to
mediate nutrient uptake and hydrolysis of extracellular
ATP [45-47]. Similar results have been obtained with
components of ABC transporters of E. coli, Brucella sp.
and Streptococcus gordonii [48-50].
Southern Blot analysis of genomic DNA of all Bifido-
bacterium strains tested for adhesion revealed a signal
only for B. bifidum strains suggesting that only this spe-
cies harbours homologues of bopA (Figure 3A). This
data corroborates the observation of a previous study,
which demonstrated the presence of BopA in eight B.
bifidum strains but not in other Bifidobacterium strains
as shown by PCR [20]. Northern blot analysis with the
B. bifidum strains showed that bopA is expressed in
these strains under conditions used to cultivate bacteria
for adhesion assays. However, expression of bopA was
variable amongst the strains and no apparent correlation
between bopA mRNA levels as detected by Northern
blot and adhesion could be observed.
To experimentally confirm these results, the involve-
ment of BopA on adhesion of B. bifidum S17 was tested
by enzymatically altering different surface components.
Adhesion of intact bacteria was inhibited significantly by






































Figure 6 Adhesion of bifidobacteria overexpressing bopA. His6-specific Western Blot on lysates of B. bifidum S17 (wt), B. bifidum S17
pMGS_Pgap_bopAHis6 (A) or B. longum/infantis E18 (wt), and B. longum/infantis E18 pMGS_Pgap_bopAHis6 (B) grown for 16 h. Lysates of E. coli
DH10B pMGS_Pgap_bopAHis6 were used as positive control for detection of BopA-His6. Adhesion of B. bifidum S17 pMGS_Pgap_bopAHis6 (C) and
B. longum/infantis E18 pMGS_Pgap_bopAHis6 (D) to T84 (black bars), Caco-2 (light grey bars) and HT29 (dark grey bars) cells compared to their
parental wildtype strains. Results are expressed as percent adherent bacteria relative to the initially added colony forming units. Values are
mean± standard deviation of one representative of at least three independent experiments performed in triplicate measurements. Statistical
analysis was performed by pairwise comparison to the respective positive control (i.e. adhesion of B. bifidum S17 or B. longum/infantis E18
wildtype) using Students t-test. Letters above bars indicate statistical significance (a: p< 0.05; b: p< 0.01; c: p< 0.001).
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B. bifidum S17 to IECs is, at least partially, mediated by
proteinaceous structures of the cell surface, which would
be the expected location for an adhesin.
Slight differences in the effects of treatments with
pronase, lipase or periodate were observed between
the cell lines used for experiments. Caco-2 and T84
cells differentiate to columnar epithelial cells and
HT29 cells remain undifferentiated. Differential ex-
pression of receptor molecules on the surface might
explain the differences between cell lines and cell
fractions. Of note, a slight reduction in adhesion of
intact bacteria was also observed for some cell lines
after lipase treatment. These effects were only mar-
ginal and statistically not significant. Lipase treatment
might alter the structure and composition of mem-
brane lipids. Since BopA is a lipoprotein anchored to
the cytoplasmatic membrane, alterations in the lipids
of the membrane provide a possible explanation for
the effects of lipase treatment.To further investigate the role of BopA for adhesion
of B. bifidum S17, a C-terminal His-tag fusion of the
protein was purified after overexpression in E. coli
BL21 (DE3). Adhesion of B. bifidum S17 to T84, Caco-
2 and HT29 cells was significantly inhibited in compe-
tition to purified BopA protein, indicating that BopA
interferes with the adhesion mechanism of B. bifidum
S17 to IECs. Pre-incubation with higher concentration
of purified BopA improved the statistical significance
but did not increase the effect on adhesion of B. bifi-
dum S17 to the tested cell lines. This indicates a satur-
ation of receptor binding sites on the epithelial surface
already at lower concentrations. This observation is in
line with experimental data of adhesion studies with
purified adhesion proteins of other organisms. For in-
stance, the purified OmpA-like protein Lsa66 of Lep-
tospira interrogans was shown to bind extracellular
matrix (ECM) components specifically and saturable
[51]. Furthermore, saturable fibronectin binding was
shown for the CssA subunit of colonisation factor CS6
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pylobacter jejuni adhesin FlpA [53].
The fact that inhibition of adhesion by purified BopA
or after pre-treatment with pronase, lipase or periodate
was incomplete points towards additional mechanisms
of adhesion that are not affected by the treatments. The
involvement of different adhesion mechanisms has been
shown for the probiotic L. rhamnosus GG for which
three different surface-localised components with a role
in adhesion were identified [54]. Cooperative effects of
different mechanisms of adhesion could represent a
strategy of bifidobacteria (and other microorganisms) to
increase their chances to successfully colonize the GIT.
Two recent studies demonstrated that various Bifidobac-
terium strains express pili on their surface, which at least
in one case are essential for host colonization [55,56].
Analysis of the genome of B. bifidum S17 revealed that
the strain harbours three clusters of genes with high
homology to pilus-coding genes of other bifidobacteria
(data not shown). Several other genes encoding for pro-
teins containing domains with known or suspected roles
in adhesion to host tissues were identified in the genome
of B. bifidum S17. Other studies indicate that surface
hydrophobicity correlates with the adhesive capacity of
bifidobacteria [8,57]. However, the actual relevance of
the abovementioned factors to adhesion of B. bifidum
S17 remain to be investigated experimentally.
To further corroborate the role of BopA for adhesion
of B. bifidum S17, a vector for expression of bopA in
bifidobacteria was constructed. In previous studies the
Pgap promoter driving expression of gap, i.e. the gene en-
coding glycerinaldehyde-3-phosphate dehydrogenase,
was successfully used for heterologous expression of
proteins in bifidobacteria [33,58,59]. Thus, the vector
pMGS_Pgap_bopAHis6 was constructed for Pgap-driven
expression of BopA-His6 in bifidobacteria. This vector
was successfully transformed into B. bifidum S17 and B.
longum/infantis E18. Unfortunately, no additional pro-
tein band corresponding to BopA-His6 could be detected
in crude extracts of the recombinant strains by SDS-
PAGE (data not shown). Detection of proteins expressed
in bifidobacteria by SDS-PAGE seems to be difficult
since to the best of our knowledge no studies showing
overexpression in bifidobacteria by SDS-PAGE are avail-
able. In those studies that provide protein data, success-
ful expression of proteins in bifidobacteria is
demonstrated by Western Blot analysis [59,60]. Indeed,
Western Blot analysis using a His6-specific antibody
confirmed the presence of BopA-His6 both in B. bifidum
S17 pMGS_Pgap_bopAHis6 and B. longum/infantis E18
pMGS_Pgap_bopAHis6.
These strains were then used in adhesion experiments
and compared to their parental wildtype strains. Overex-
pression of bopA in B. bifidum S17 significantlyincreased adhesion to IECs. More importantly, expres-
sion of bopA in B. longum/infantis E18, a strain that
does not encode for a BopA homologue as shown by
Southern Blot (Figure 3A) and displays extremely weak
adhesion to IECs (Figure 1), led to a dramatic increase
in adhesion to all cell lines tested. Overall, the effect on
adhesion with B. longum/infantis E18 overexpressing
bopA was by far more prominent than with B. bifidum
S17 pMGS_Pgap_bopAHis6. This can be explained with
the fact that the adhesin BopA is not present in B.
longum/infantis E18 wildtype. In contrast, expression of
BopA in B. bifidum S17 enhanced adhesion to IECs to a
lesser extent, because BopA-His6 is expressed additional
to wildtype BopA in this strain.
Conclusions
Collectively, these results identify BopA as an adhesin
mediating adhesion of B. bifidum strains to IECs. Fur-
thermore, increased adhesion of B. bifidum S17 and B.
longum/infantis E18 following enhanced expression of
bopA is one of the first reports on improved probiotic
characteristics of Bifidobacterium strains. Although the
use of genetically modified organisms in functional (pro-
biotic) food products is currently not accepted in the
European markets, the tools generated in the present
study are suitable to generate recombinant bifidobacteria
with optimised probiotic characteristics. To our know-
ledge, our study is the first report on enhanced probiotic
properties by expression of a bifidobacterial adhesin in
strains of Bifidobacterium. The only other study so far
has shown prolonged colonisation of a B. breve strain
expressing a gene involved in bile resistance of Listeria
monocytogenes [61]. Besides this, only a limited number
of studies demonstrate improved probiotic properties of
recombinant lactic acid bacteria. One example is a re-
combinant Lactobacillus paracasei strain expressing
the gene coding for the Listeria adhesion protein
(Lap), which was shown to protect Caco-2 cells from
infection with Listeria monocytogenes by interaction
with host cell receptor Hsp60 [62]. In further studies,
the relevance of BopA for in vivo colonisation will be
investigated. Furthermore, additional factors that are
involved in adhesion of B. bifidum S17 need to be
identified to completely understand the mechanisms of
adhesion of this promising anti-inflammatory probiotic
organism.
Materials and methods
Bacterial strains and culture conditions
Bifidobacteria (Table 1) were grown in Lactobacilli
MRS medium (Difco) supplemented with 0.5 g/l L-cyst-
eine (MRSC) for 16 h to stationary phase at 37 °C
under anaerobic conditions. In addition, E. coli strains
(Table 1) DH10B and BL21 (DE3) were used for cloning
Gleinser et al. Microbial Cell Factories 2012, 11:80 Page 10 of 14
http://www.microbialcellfactories.com/content/11/1/80and protein expression, respectively. E. coli was culti-
vated in 2× Trypton Yeast (TY) medium and grown to
stationary phase at 37 °C with agitation. For cultivation
of strains harbouring plasmids, the respective medium
was supplemented with 100 μg/ml spectinomycin.
Culture conditions of intestinal epithelial cells
Eukaryotic cell lines T84 (ATCC), Caco-2 (ATCC) and
HT29 (DSMZ) were maintained in DMEM/Ham’s F12
or DMEM medium, respectively. Medium for T84 cells
was supplemented with 10% (v/v) heat-inactivated foetal
calf serum (FCS), and 1% (v/v) penicillin-streptomycin
solution. Medium for Caco-2 cells was supplemented
with 10% (v/v) FCS, 1% (v/v) non-essential amino acids
(NEAA), and 1% (v/v) penicillin-streptomycin solution
and for HT29 cells with 5% (v/v) FCS, 1% (v/v) NEAA,
and 1% (v/v) penicillin-streptomycin solution. Cells were
incubated in cell culture incubators at 37 °C with 5%
CO2. Medium was changed every two to three days and
cells were subcultured according to supplier’s guidelines.
For experiments, cells were grown for 9–11 (T84) or
18–21 (Caco-2) days to fully differentiated monolayers.
HT29 cells were used as undifferentiated monolayers at
90–95% confluence, i.e. approximately five days after
seeding. At this stage about 1 × 108 cells were counted
per well for all cell lines.
Adhesion assay
Prior to incubation with bacteria, normal medium of the
cells was replaced with cell culture medium without
serum and antibiotics. For adhesion assays, bacteria were
grown for 16 h under appropriate conditions and washed
once in phosphate buffered saline (PBS; pH 7.4) and
adjusted to an OD600 corresponding to 1 × 10
9 colony
forming units (cfu) per ml in PBS. 100 μl (or 1 × 108 cfu)
of this bacterial suspension were added to each well.
After incubation for 1 h at 37 °C non-adherent bacteria
were removed by washing cells three times with PBS. Cell
monolayers were then lysed by the addition of ice-cold
bidistilled H2O and serial ten-fold dilutions in PBS were
plated in spots of 10 μl on MRSC-agar plates to enumer-
ate cfu of adherent bacteria. Adhesion of the bacteria to
the eukaryotic cells was then calculated as percentage of
the number of bacteria initially added to the wells, which
was determined by spot plating of the bacterial suspen-
sion added to the monolayers. All adhesion experiments
were performed at least in three independent biological
replicates, i.e. bacteria of three independent bacterial cul-
tures were tested on cells of different passages.
To test adhesion of bifidobacteria in competition puri-
fied protein experiments were carried out as described
above using monolayers that were pre-treated for 1 h
with purified BopA (100 μg, 10 μg or 1 μg total protein
as indicated). In these experiments, adhesion of thebacteria to the eukaryotic cells was calculated as per-
centage of adherent bacteria relative to the positive con-
trol (no purified BopA protein).Treatment of B. bifidum S17 and viability test
To digest proteins, carbohydrates or lipids on the cell sur-
face of B. bifidum S17, bacteria were grown under standard
conditions. After centrifugation (10 min, 5,000×g) bacteria
were washed once with PBS and adjusted to an OD600 cor-
responding to 1×109 cfu/ml and treated with lipase (1 mg/
ml in PBS), pronase (1 mg/ml in pronase buffer: 10 mM so-
dium acetate, 5 mM potassium acetate, pH 7.5) or period-
ate (1 mM in 1 M glycine). Untreated and periodate-treated
bacteria were incubated in the dark at RT with agitation
whereas pronase- and lipase-treated bacteria were incu-
bated at 37 °C in a water bath. Treatments were maintained
for up to 60 min as indicated in the Results section. For ad-
hesion experiments cells were treated for 30 min, then cen-
trifuged (10 min, 14,000× g) and washed once with PBS.
To apply treated bacteria to adhesion assays, bacteria were
pelleted by centrifugation and OD600 was re-adjusted to ob-
tain 1×108 cfu/ml. Adhesion of treated bacteria was tested
as described and calculated as percentage of adherent bac-
teria relative to the positive control (untreated bacteria),
which was set to 100%.
To check viability of bacteria during and after the
treatment, samples were taken after 0, 15, 30, 45 and
60 min and serial dilutions were plated on MRSC agar
plates to determine cfu counts. Furthermore, cell wall
fractions of bacteria were prepared of samples at dif-
ferent time points during the treatments as by pellet-
ing bacteria and resuspension in lysis buffer (1M
sucrose, 11.4 mM PMSF, and 15 mg/ml lysozyme in
50 mM Tris-HCl; pH 7.6). After incubation for 90 min
at 37 °C protoplasts were pelleted by three centrifuga-
tions at 1,500 xg for 1 min and the supernatant was
retained representing the cell wall fraction.Southern blot
Southern Blot was performed according to a standard
protocol [63] using EcoRI-digested chromosomal DNA of
Bifidobacterium strains (Table 1) separated on a 0.8% (w/v)
agarose gel and blotted on a nylon membrane (GE Health-
care). For detection of bopA homologues, a digoxygenin-
11-dUTP-labelled probe was amplified by PCR using
chromosomal DNA of B. bifidum S17 as template and the
oligonucleotides bopA_f_SB (5’-CTCGTGCTGTTCAG-
GAGAGG-3’) and bopA_r_SB (5’-TCACTTCTCC-
CAGCCGAGGTTC-3’). Detection of the hybridised probes
was performed using an anti-digoxygenin antibody coupled
to the enzyme alkaline phosphatase (Cat. #11 093 274 910,
Roche) and visualised on an X-ray film using a commercial
CSPD substrate (Roche).
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For Northern Blot, RNA was isolated using a standard
protocol [63] from B. bifidum strains (Table 1) after
growth for 16 h under standard conditions. Briefly, bac-
teria were mixed with Quenching buffer (60% (v/v)
methanol, 66.7 mM HEPES, pH 6.5, -40 °C) and har-
vested by centrifugation (4,000 × g, 20 min, 4 °C). The
pellet was resuspended in 200 μl ice-cold H2O and
mixed with 400 μl phenol (pH 4.5-5), 100 μl chloroform,
30 μl 10% (w/v) SDS, 30 μl sodium acetate (3 M, pH 5.2)
and 250 mg glass beads to disrupt bacteria in a RiboLy-
ser (3 cycles, each for 40 seconds at 4 °C) set to full
speed. Cell debris, glass beads and phenol/chloroform
were removed by centrifugation (15 min, 14,000 × g,
4 °C). The aqueous phase containing RNA was mixed
with 1.5 volumes of 99% ethanol and incubated o/N at
−20 °C. After centrifugation (14,000 × g, 15 min, 4 °C)
the pellet was washed once with ice-cold 70% (v/v)
ethanol and air-dried. The dry pellet was resuspended
in H2O and RNA concentration was determined by
measuring absorbance at 260 nm.
Residual DNA was removed by a treatment with
DNaseI, which was repeated until no DNA was left in
the RNA sample, which was checked by PCR using
primers specific for 16 S rDNA (16S_fD1: 5’-
AGAGTTTGATCCTGGCTCAG-3’ and 16S_rP2: 5’-
ACGGCTACCTTGTTACGACTT-3’, [64]) and RNA
sample as template. Following the DNaseI treatment
RNA samples were purified using the RNeasy Mini
Kit (Qiagen) according to manufacturer’s instructions.
DNA-free RNA was separated on a 0.8% (w/v) agarose
gel supplemented with 10% (v/v) formaldehyde (37%)
and blotted onto a nylon membrane (GE Healthcare). A
digoxygenin-11-dUTP-labelled DNA probe complemen-
tary to the target RNA molecule was amplified by PCR
using chromosomal DNA of B. bifidum S17 as template
and the oligonucleotides bopA_f_NB (5’-AAGGTCCAG-
AGCGGCAAGAG-3’) and bopA_r_NB (5’-CACACCG-
GAGTCGTAGGAAC-3’), hybridised to the membrane
and detected as described above.
Purification of the B. bifidum S17 BopA protein
For expression of bopA in E. coli BL21 (DE3), a vector
was constructed based on the previously published re-
porter plasmid pMDY23 ([33], Table 1). The gusA gene
encoded on pMDY23 was removed together with a range
of restriction sites by amplification of the pMDY23 vec-
tor backbone using the oligonucleotides gusA_f_FspI (5’-
TGCGCAGCCTCAGCCTGCGGAACGCGC-3’, FspI
site underlined) and gusA_r_FspI (5’-TGCGCAGCTG-
TAGACCAAGTTTACTC-3’, FspI site underlined). The
vector backbone was then digested with FspI and ligated
to the multiple cloning site of pBluescript, which was
amplified using the oligonucleotides T3 (5’-AATTAAC-CCTCACTAAAGGG-3’) and T7 (5’-TAATACGACTCA-
CTATAGGG-3’), resulting in the E. coli-Bifidobacterium
shuttle vector pMGS. For arabinose-inducible expression,
the araC gene and PBAD were amplified from pREDI [65]
using the oligonucleotides pBAD_f_SacII (5’-CAT-
CATCCGCGGTTATTATGACAACTTGACG-3’, SacII
site is underlined) and pBAD_r_SpeI (5’-CATCATAC-
TAGTACCCTCCTTAGAGCTCG-3’, SpeI site is under-
lined). The PCR product was digested using restriction
enzymes SacII and SpeI and ligated to the SpeI/SacII-
digested pMGS plasmid resulting in the vector
pMGS_PBAD. The sequence of bopA was amplified by
PCR using chromosomal DNA of B. bifidum S17 and the
oligonucleotides bopA_f_SpeI (5’-GGACTAGTATGA-
GTTTTGCATCTACCGC-3’, SpeI site is underlined) and
bopAHis_r_HindIII (5’-CCCAAGCTTTCAGTGGTGG-
TGGTGGTGGTGCTTCTCCCAGCCGAGGTTC-3’, Hin-
dIII site is underlined). The SpeI- and HindIII-digested
PCR fragment was ligated to the SpeI/HindIII cut plas-
mid pMGS_PBAD and the resulting plasmid
(pMGS_PBAD_bopAHis6) was transformed in E. coli BL21
(DE3). For production of recombinant BopA-His6, E. coli
BL21 (DE3) pMGS_PBAD_bopAHis6 was cultivated in 2×
TY medium supplemented with 100 μg/ml spectino-
mycin, under standard conditions until an OD600 of 0.5
was reached. Expression of bopA was induced by
addition of 0.013 mM L-arabinose and bacteria were
grown for further 3 h at 37 °C with agitation to accu-
mulate recombinant BopA. Then bacteria were har-
vested by centrifugation (4 °C, 5,000 × g, 10 min), and
washed once with binding buffer (30 mM Tris,
500 mM NaCl, 5 mM imidazole, 30% (v/v) glycerol,
pH 7.9). Bacterial cells were disrupted using a French
Press at a pressure of 850 PSI. The cytoplasmic frac-
tion was obtained from the lysate by centrifugation at
4 °C, 250,000 × g for 1.5 h in an ultracentrifuge. For
purification of BopA-His6 by Ni-NTA affinity chroma-
tography, the cytoplasmic fraction was loaded on a
1 ml HisTrap FF column (GE Healthcare) fitted to an
ÄKTA FPLC purifier system (GE Healthcare), which
was calibrated prior to loading with elution buffer
(30 mM Tris, 500 mM NaCl, 500 mM imidazole, 30%
(v/v) glycerol, pH 7.9) and then with binding buffer.
Bound protein was eluted by a linear imidazole gradi-
ent (5 mM to 500 mM). The eluate was collected and
respective fractions were run on a SDS-PAGE to check
for size and purity of the recombinant protein. Pure
fractions showing a signal of the expected size were
pooled and subsequently dialysed against 20% (v/v)
glycerol solution (o/N, 4 °C) to remove imidazole from
the buffer. After dialysis, purified protein was concen-
trated by incubation of dialysis tubes in polyethylene
glycol (PEG 20.000) for 2–3 h. To apply a defined pro-
tein amount to adhesion assays, protein concentration
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Scientific).Western blot
For Western Blot analysis, equivalent amounts of protein
as determined by BCA protein assay were separated by
SDS-PAGE and subsequently electroblotted onto nitro-
cellulose membrane. After blocking of unspecific protein
binding with blocking buffer (5% milk powder in PBS),
nitrocellulose membrane was incubated with anti-His6
antibody (1:1,000 in PBS; Cat. #11922416001, Roche) for
1 h at room temperature. After three washings with
PBS, the membrane was incubated with a rabbit-anti-
mouse horseradish peroxidase-coupled secondary anti-
body (1:10,000 in blocking buffer; Cat. #31430, Thermo
Scientific) for 1 h at room temperature. Detection of
horseradish peroxidase was performed using ECL West-
ern Blotting substrate (Thermo Scientific) and chemilu-
minescence was detected on X-ray films.
Expression of bopA in bifidobacteria
For expression of bopA in B. bifidum S17 and B. longum/
infantis E18 the promoter sequence of glyceraldehyde-3-
phosphate dehydrogenase gene (BBIF_0612, Pgap) was
amplified using chromosomal DNA of B. bifidum S17
and the oligonucleotides Pgap_f_BglII (5’-GAAGATCTG-
CGGAATGCCTCGCATCGAATC-3’, BglII site under-
lined) and Pgap_r_SalI (5’-GACGACGTCGACCTCCC-
TTTGTAGGGTAGA-3’, SalI site underlined) and ligated
in the BglII and SalI-cut plasmid pMGS yielding
pMGS_Pgap. The coding sequence of bopA was amplified
by PCR using chromosomal DNA of B. bifidum S17 and
the oligonucleotides bopA_f_SalI (5’-GACGTAGTCGA-
CATGAGTTTTGCATCTACCGC-‘3, SalI site under-
lined) and bopAHis_r_HindIII (5’-CCCAAGCTTTC-
AGTGGTGGTGGTGGTGGTGCTTCTCCCAGCCGA-
GGTTC-3’, HindIII site underlined) and the SalI- and
HindIII-digested PCR fragment was ligated to the SalI/
HindIII cut plasmid pMGS_Pgap. The resulting plasmid
(pMGS_Pgap_bopAHis6) was transformed in B. bifidum
S17 and B. longum/infantis E18 to test adhesion with
constitutively overexpressed bopA.Additional files
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